by PEAK Medicals | 15 November 2024
DISKUSSIONSFORUM FÜR URO-ONKOLOGIE Neue Standards im Urothelkarzinom und das Management ihrer Nebenwirkungen Maria De Santis Prostatakarzinom: Wie lassen sich die neuen Therapien für mHSPC und mCRPC integrieren? Shahrokh F. Shariat Neue Behandlungsmöglichkeiten beim...
by PEAK Medicals | 5 June 2024
GU Cancers (ASCO 2024) Welcome & introduction by host Alex Friedlaender How do the data from ASCO integrate into the treatment of prostate cancer? Berna Özdemir Latest treatment advances for renal cell carcinoma Giuseppe Banna New breakthroughs in urothelial cancer...
by PEAK Medicals | 27 March 2024
Prostate & Urothelial Cancer Welcome & introduction by host Aurelius Omlin How to integrate the new treatment options in mHSPC and mCRPC Deborah Mukherji First-line mUC: how to manage patients on the enfortumab-pembrolizumab combination Alison Birtle Open...
by PEAK Medicals | 7 June 2023
GU Cancers (ASCO 2023) Welcome & introduction by host Berna Özdemir Latest advances for the treatment of renal cell carcinoma Yüksel Ürün How do the data from ASCO integrate into the treatment of prostate cancer? Carmel Pezaro Latest treatment updates in urothelial...
by PEAK Medicals | 22 March 2023
Prostate Cancer Welcome & introduction by host Aurelius Omlin Metastatic hormone-sensitive prostate cancer Deborah Mukherji Metastatic castration-resistant prostate cancer Alison Birtle Open discussion, viewer questions & patient cases Aurelius Omlin  } 1 h 37...
